Michael D. Swanson

1.8k total citations
26 papers, 1.3k citations indexed

About

Michael D. Swanson is a scholar working on Virology, Infectious Diseases and Molecular Biology. According to data from OpenAlex, Michael D. Swanson has authored 26 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Virology, 9 papers in Infectious Diseases and 8 papers in Molecular Biology. Recurrent topics in Michael D. Swanson's work include HIV Research and Treatment (15 papers), HIV/AIDS Research and Interventions (6 papers) and Monoclonal and Polyclonal Antibodies Research (5 papers). Michael D. Swanson is often cited by papers focused on HIV Research and Treatment (15 papers), HIV/AIDS Research and Interventions (6 papers) and Monoclonal and Polyclonal Antibodies Research (5 papers). Michael D. Swanson collaborates with scholars based in United States, Denmark and Belgium. Michael D. Swanson's co-authors include David M. Markovitz, J. Víctor García, Irwin Goldstein, Harry C. Winter, Morgan Chateau, Marta J. Gonzalez-Hernandez, Paul W. Denton, Angela Wahl, Ioan Andricioaei and Hashim M. Al‐Hashimi and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Nature Communications.

In The Last Decade

Michael D. Swanson

25 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael D. Swanson United States 17 538 467 345 328 189 26 1.3k
Thierry Huet France 13 423 0.8× 713 1.5× 482 1.4× 203 0.6× 296 1.6× 18 1.2k
Heinrich Hohenberg Germany 17 447 0.8× 380 0.8× 177 0.5× 239 0.7× 342 1.8× 23 1.4k
Michael Dolan United States 22 673 1.3× 175 0.4× 377 1.1× 274 0.8× 263 1.4× 52 1.3k
Mario Amacker Switzerland 20 967 1.8× 367 0.8× 501 1.5× 563 1.7× 449 2.4× 45 2.1k
Olga Latinovic United States 14 324 0.6× 531 1.1× 326 0.9× 345 1.1× 263 1.4× 40 1.1k
Xin Ji China 17 403 0.7× 156 0.3× 201 0.6× 650 2.0× 156 0.8× 42 1.3k
Suganya Selvarajah United States 12 529 1.0× 300 0.6× 248 0.7× 203 0.6× 399 2.1× 20 1.3k
Sundarasamy Mahalingam India 25 1.2k 2.2× 985 2.1× 630 1.8× 713 2.2× 272 1.4× 60 2.2k
Johannes S. Gach United States 17 543 1.0× 681 1.5× 260 0.8× 502 1.5× 145 0.8× 42 1.2k
Matthew D. Marsden United States 23 560 1.0× 937 2.0× 665 1.9× 682 2.1× 277 1.5× 42 1.8k

Countries citing papers authored by Michael D. Swanson

Since Specialization
Citations

This map shows the geographic impact of Michael D. Swanson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael D. Swanson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael D. Swanson more than expected).

Fields of papers citing papers by Michael D. Swanson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael D. Swanson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael D. Swanson. The network helps show where Michael D. Swanson may publish in the future.

Co-authorship network of co-authors of Michael D. Swanson

This figure shows the co-authorship network connecting the top 25 collaborators of Michael D. Swanson. A scholar is included among the top collaborators of Michael D. Swanson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael D. Swanson. Michael D. Swanson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gupta, Paridhi, Ashish Srivastava, Josiah Ryman, et al.. (2025). Short-Term Immunosuppression in Rats Induces Prolonged Immune Tolerance Towards a Human Monoclonal Antibody, Erenumab. The AAPS Journal. 27(4). 94–94.
2.
Phuah, Jia Yao, Brian M. Maas, Aimin Tang, et al.. (2023). Quantification of clesrovimab, an investigational, half-life extended, anti-respiratory syncytial virus protein F human monoclonal antibody in the nasal epithelial lining fluid of healthy adults. Biomedicine & Pharmacotherapy. 169. 115851–115851. 22 indexed citations
3.
Swanson, Michael D., Nicole Sullivan, Debbie Nahas, et al.. (2023). Phage-Derived Anti-Idiotype and Anti-YTE Antibodies in Development of MK-1654 Pharmacokinetic and Immune Response Assays. Bioanalysis. 15(16). 1049–1067. 2 indexed citations
4.
Swanson, Michael D., et al.. (2022). Immunogenicity Risk Assessment of Spontaneously Occurring Therapeutic Monoclonal Antibody Aggregates. Frontiers in Immunology. 13. 915412–915412. 16 indexed citations
5.
Jawa, Vibha, Jad Maamary, Michael D. Swanson, Shuli Zhang, & Diana Montgomery. (2022). Implementing a Clinical Immunogenicity Strategy using Preclinical Risk Assessment Outputs. Journal of Pharmaceutical Sciences. 111(4). 960–969. 9 indexed citations
7.
King, Steven, Maureen Legendre, Michael D. Swanson, et al.. (2021). Targeted disruption of pi–pi stacking in Malaysian banana lectin reduces mitogenicity while preserving antiviral activity. Scientific Reports. 11(1). 656–656. 18 indexed citations
8.
Benhabbour, S. Rahima, Martina Kovářová, Roopali Shrivastava, et al.. (2019). Ultra-long-acting tunable biodegradable and removable controlled release implants for drug delivery. Nature Communications. 10(1). 4324–4324. 112 indexed citations
9.
Honeycutt, Jenna B., Baolin Liao, Christopher C. Nixon, et al.. (2018). T cells establish and maintain CNS viral infection in HIV-infected humanized mice. Journal of Clinical Investigation. 128(7). 2862–2876. 42 indexed citations
10.
Wu, Guoxin, Michael D. Swanson, Aarthi Talla, et al.. (2017). HDAC inhibition induces HIV-1 protein and enables immune-based clearance following latency reversal. JCI Insight. 2(16). 50 indexed citations
11.
Kovářová, Martina, Michael D. Swanson, Rosa I. Sánchez, et al.. (2016). A long-acting formulation of the integrase inhibitor raltegravir protects humanized BLT mice from repeated high-dose vaginal HIV challenges. Journal of Antimicrobial Chemotherapy. 71(6). 1586–1596. 26 indexed citations
12.
Swanson, Michael D., Rae Ann Spagnuolo, Angela Wahl, & J. Víctor García. (2015). Role of Semen on Vaginal HIV-1 Transmission and Maraviroc Protection. Antimicrobial Agents and Chemotherapy. 59(12). 7847–7851. 13 indexed citations
13.
Wahl, Angela, et al.. (2014). The Role of Semen on Vaginal HIV-1 Transmission and on the Efficacy of Maraviroc as a Topically Applied Microbicide. AIDS Research and Human Retroviruses. 30(S1). A50–A50. 1 indexed citations
14.
Mor‐Vaknin, Nirit, Maureen Legendre, Yue Yu, et al.. (2013). Murine Colitis is Mediated by Vimentin. Scientific Reports. 3(1). 1045–1045. 51 indexed citations
15.
Chateau, Morgan, Paul W. Denton, Michael D. Swanson, Ian McGowan, & J. Víctor García. (2013). Rectal Transmission of Transmitted/Founder HIV-1 Is Efficiently Prevented by Topical 1% Tenofovir in BLT Humanized Mice. PLoS ONE. 8(3). e60024–e60024. 51 indexed citations
16.
Férir, Geoffrey, Dana Huskens, Kenneth E. Palmer, et al.. (2012). Combinations of Griffithsin with Other Carbohydrate-Binding Agents Demonstrate Superior Activity Against HIV Type 1, HIV Type 2, and Selected Carbohydrate-Binding Agent-Resistant HIV Type 1 Strains. AIDS Research and Human Retroviruses. 28(11). 1513–1523. 37 indexed citations
17.
Wahl, Angela, Michael D. Swanson, Tomonori Nochi, et al.. (2012). Human Breast Milk and Antiretrovirals Dramatically Reduce Oral HIV-1 Transmission in BLT Humanized Mice. PLoS Pathogens. 8(6). e1002732–e1002732. 73 indexed citations
18.
Stelzer, Andrew C., Aaron T. Frank, Jeremy D. Kratz, et al.. (2011). Discovery of selective bioactive small molecules by targeting an RNA dynamic ensemble. Nature Chemical Biology. 7(8). 553–559. 223 indexed citations
19.
Férir, Geoffrey, Kurt Vermeire, Dana Huskens, et al.. (2011). Synergistic in vitro anti-HIV type 1 activity of tenofovir with carbohydrate-binding agents (CBAs). Antiviral Research. 90(3). 200–204. 14 indexed citations
20.
Swanson, Michael D., Harry C. Winter, Irwin Goldstein, & David M. Markovitz. (2010). A Lectin Isolated from Bananas Is a Potent Inhibitor of HIV Replication. Journal of Biological Chemistry. 285(12). 8646–8655. 166 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026